A Study to Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naïve Subjects Not Part of H03_01TP Study
Clinical trial NCT03089879 · COMPLETED
Trial details
- NCT number
- NCT03089879
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-16
- Primary completion
- 2017-08-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.